TLSIWTriSalus Life Sciences, Inc.vs its industry peers
A metric-by-metric comparison of TriSalus Life Sciences, Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TLSIWThis | $55M#8 | — | 8.5x#11 | 1.2x#6 | 53.4%#2 | -30.6%#11 | -59.7%#9 | -598.9%#10 | — | 5#4 | -61.7%#3 | — |
| GUTS | $95M#1 | — | — | — | -100.0%#13 | -105.2%#13 | — | — | — | — | — | — |
| LNSR | $88M#2 | 35.8x#4 | 5.9x#10 | 1.7x#7 | 12.4%#6 | -9.2%#9 | -47.6%#7 | -230.0%#8 | — | — | — | — |
| SKIN | $87M#3 | — | 1.6x#6 | 0.3x#1 | -10.0%#9 | 67.4%#3 | -6.9%#3 | -17.1%#3 | — | — | — | — |
| LUNG | $85M#4 | — | 2.2x#8 | 0.9x#5 | 8.0%#7 | 4.2%#6 | -59.3%#8 | -137.8%#6 | -257.0%#5 | 3#5 | 28.4%#1 | — |
| DRIO | $65M#5 | 1.2x#2 | 1.2x#3 | 2.9x#11 | -17.3%#10 | 2.4%#7 | -163.9%#10 | -75.7%#5 | -41.6%#3 | 3#5 | — | — |
| SKYA | $57M#6 | — | 0.4x#1 | 280.1x#13 | — | -2938.9%#15 | -132145.5%#13 | -179.6%#7 | -181.9%#4 | — | — | — |
| TELA | $56M#7 | — | — | 0.7x#4 | 15.8%#4 | -2.6%#8 | -42.0%#5 | — | -257.2%#6 | 3#5 | — | — |
| MDAI | $51M#9 | — | — | 2.6x#10 | -33.6%#11 | 50.1%#4 | -43.8%#6 | — | — | 3#5 | — | — |
| SRTS | $50M#10 | — | 1.4x#5 | 1.8x#8 | -34.3%#12 | -216.1%#14 | -37.5%#4 | -20.9%#4 | — | — | — | — |
| NEPH | $48M#11 | 27.6x#3 | 5.7x#9 | 2.6x#9 | 32.7%#3 | 1513.5%#1 | 6.1%#1 | 14.3%#1 | 26.8%#1 | 7#1 | -2.5%#2 | — |
| AMIX | $4M#14 | — | 1.3x#4 | — | — | -46.5%#12 | — | -528.6%#9 | -743.5%#9 | — | — | — |
| XAIR | $3M#15 | 0.2x#1 | 1.6x#7 | 0.4x#3 | 107.3%#1 | 28.7%#5 | -378.2%#11 | -1664.9%#12 | -347.6%#7 | 7#1 | — | — |
| XTNT | $45M#12 | — | 1.1x#2 | 0.3x#2 | 14.2%#5 | 130.2%#2 | 5.4%#2 | 0.0%#2 | 5.0%#2 | 7#1 | — | — |
| PETV | $39M#13 | — | 28.5x#12 | 33.9x#12 | 0.8%#8 | -24.7%#10 | -793.9%#12 | -772.3%#11 | -647.5%#8 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice